NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

闌尾炎診斷及治療的全球市場(2021年∼2028年)

Global Appendicitis Diagnostics and Treatment Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1015017
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
闌尾炎診斷及治療的全球市場(2021年∼2028年) Global Appendicitis Diagnostics and Treatment Market - 2021-2028
出版日期: 2021年06月22日內容資訊: 英文 180 Pages
簡介

推動全球闌尾炎診斷及治療市場預測期間的成長的要素,是闌尾炎的盛行率上升和對闌尾炎的診斷及治療的選項需求高漲。再加上兒童闌尾炎的發生率上升也是推動市場的主要原因之一。

COVID-19大流行,給予全球醫療系統影響。急性闌尾炎是美國最常見的急診手術,如果不進行醫療或手術介入,則不太可能改善。在2020年COVID-19大流行的第一波期間,急性闌尾炎的發病率略有下降。然而,與2019年相比,延遲且患有複雜性闌尾炎的患者數量有所增加。

本報告提供全球闌尾炎診斷及治療市場的相關調查,市場機會和影響,成長及阻礙因素,COVID-19的影響,類型、診斷及治療、終端用戶、各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 全球闌尾炎診斷及治療市場:調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球闌尾炎診斷及治療市場:市場定義和概要

第3章 全球闌尾炎診斷及治療市場:摘要整理

  • 各類型的市場明細
  • 各診斷及治療市場明細
  • 各終端用戶市場明細

第4章 全球闌尾炎診斷及治療市場:市場動態

  • 影響市場的要素
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球闌尾炎診斷及治療市場:產業分析

  • 波特的五力分析
  • 流行病學分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球闌尾炎診斷及治療市場:COVID-19分析

  • 市場上的Covid-19分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後或今後方案
  • Covid-19的價格趨勢
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球闌尾炎診斷及治療市場:各類型

  • 簡介
    • 市場規模分析及與前一年同期比較成長分析
    • 市場魅力指數
  • 急性
  • 慢性

第8章 全球闌尾炎診斷及治療市場:各診斷及治療

  • 簡介
    • 市場規模分析及與前一年同期比較成長分析
    • 市場魅力指數
  • 診斷
    • 超音波成像
    • 電腦斷層掃描
    • 其他
  • 手術
    • 投藥
    • 手術
  • 其他

第9章 全球闌尾炎診斷及治療市場:各終端用戶

  • 簡介
    • 市場規模分析及與前一年同期比較成長分析
    • 市場魅力指數
  • 醫院及診療所
  • 診斷中心

第10章 全球闌尾炎診斷及治療市場:各地區

  • 簡介
    • 市場規模分析(2018-2028),及與前一年同期比較成長分析(2020-2028)
    • 各地區的市場魅力指數
  • 北美
    • 簡介
    • 各主要地區的動態
    • 各類型:市場規模分析,及與前一年同期比較成長分析
    • 各診斷及治療:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 歐洲
    • 簡介
    • 各主要地區的動態
    • 各類型:市場規模分析,及與前一年同期比較成長分析
    • 各診斷及治療:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 南美
    • 簡介
    • 各主要地區的動態
    • 各類型:市場規模分析,及與前一年同期比較成長分析
    • 各診斷及治療:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 亞太地區
    • 簡介
    • 各主要地區的動態
    • 各類型:市場規模分析,及與前一年同期比較成長分析
    • 各診斷及治療:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 中東和非洲
    • 各主要地區的動態
    • 各類型:市場規模分析,及與前一年同期比較成長分析
    • 各診斷及治療:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析

第11章 全球闌尾炎診斷及治療市場:競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準
  • 值得注意的主要企業的清單
  • 創新的技術的企業的清單
  • Start-Ups企業的清單

第12章 全球闌尾炎診斷及治療市場:企業簡介概要

  • B. Braun Melsungen AG
    • 企業概要
    • 產品系列、概要
    • 要點
    • 財務概要
  • Johnson & Johnson Services Inc
  • Pfizer Inc
  • Lupin
  • Siemens
  • Koninklijke Philips NV
  • Medsinglong Co Ltd.
  • Guangzhou Medunion Technologies Co.ltd
  • Guangzhou Maya Medical Equipment.Co.ltd
  • Teva Pharmaceutical Industries Ltd

第13章 全球闌尾炎的診斷及治療市場。-DataM

  • 附錄
  • 關於本公司、服務
  • 諮詢方式

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMMD3464

Market Overview

The global appendicitis diagnostics and treatment market. size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Appendicitis is an inflammation of the appendix, a finger-shaped pouch that projects from your colon on the lower right side of the abdomen. Appendicitis causes pain in lower right abdomen. It's a medical emergency that almost always requires surgery as soon as possible to remove the appendix. While you can live just fine without it after the surgery.

Market Dynamics

The rising prevalence of appendicitis and growing demand for diagnostic and treatment options of appendicitis will drive the growth of the Global Appendicitis Diagnostics and Treatment Market. in the forecast period. In addition, the rising incidence of pediatric appendicitis is also one of the major factors propelling the market.

The rising prevalence of appendicitis and incidence of pediatric appendicitis will drive the market growth

Appendicitis mainly occurs between the age of 5 and 45, with a mean age of 28. Thus, the incidence is approximately 233/100,000 people. Males have a slightly higher predisposition of developing acute appendicitis compared to females, with a lifetime incidence of 8.6% for men and 6.7 % for women.

The prevalence of acute appendicitis is more as compared to chronic appendicitis. One out of every 15 people will develop acute appendicitis in their lifetime. More than 250,000 appendectomies are performed each year in the U.S, however, the incidence is lower in populations where a high-fiber diet is consumed. Globally, the pooled incidence of appendicitis or appendectomy is around 100 per 100,000 person-years.

Pediatric appendicitis may occur in children with cystic fibrosis, which can have a greater risk. Having a family history of appendicitis may also increase a child's risk for this condition. It can be diagnosed with the minimally invasive technique for Transumbilical Laparoscopic Assisted Appendicectomy. Laparoscopic-assisted single-port appendectomy (SPA) has not yet evolved as the gold standard but has also been performed in children and found to be safe. Appendicitis is considered as clinical diagnosis, and imaging is beneficial in doubtful cases, such as female patients of childbearing age. Different types of equipment are involved for the diagnosis of appendicitis, such as the use of ultrasound is increasing, particularly in children in whom the risks of ionizing radiation are greatest. The advantages include decreased cost relative to other imaging modalities and lack of ionizing radiation exposure. C.T. of the abdomen and pelvis is also considered the modality of choice for definitive assessment of patients evaluated for possible appendicitis. The increasing cases of appendicitis will lead to the rise of the Global Appendicitis Diagnostics and Treatment Market.

Growing demand for diagnostic and treatment options

The evaluation and treatment of acute appendicitis remain essentially unchanged for individuals with this disease. Even though advancements have been made in laboratory analysis and imaging via ultrasonography and C.T., nothing can replace careful evaluation by an experienced surgeon.

For the diagnosis of appendicitis, practitioners should interpret laboratory evaluations in association with the patient's clinical history and physical examination findings. Although lab results may help support the clinical diagnosis, they cannot replace a good history and physical examination. The implementation of laparoscopy has revolutionized surgery over the past few years, incorporating significant benefits for the patient. Laparoscopy is a minimally invasive surgery (MIS), a revolutionary procedure that has benefitted both the patients and the doctor's.Keyhole surgery (laparoscopy) is usually the preferred method of removing the appendix because the recovery tends to be quicker than with open surgery.

Difficulty in the diagnosis of appendicitis will hamper the market

Abdominal pain is the most common reason for consultation in the emergency department, and most of the time, its cause is an episode of acute appendicitis. According to a study by Medspace statistics, reports that 1 of 5 cases of appendicitis is misdiagnosed, however, a normal appendix is found in 15-40% of patients who have an emergency appendectomy. The misdiagnosis rate of acute appendicitis is high due to the unusual presentation of the symptoms. The overall accuracy for diagnosing acute appendicitis is approximately 80%, with a false-negative appendectomy rate of 20%. Diagnostic accuracy varies by sex, with a range of 78-92% in males and 58-85% in female patients.

According to University of Washington researchers, although more diagnostic tools are available now than ever, there has been no improvement in the rate of misdiagnosis of appendicitis during the last decade.

According to the study results by the Journal of the American Medical Association, despite the availability of the new tests, in nearly one of four appendectomies performed in women of childbearing age, the removed appendix is not infected. The rate of misdiagnosis among young women and older men has increased.

Industry Analysis

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted the healthcare systems globally. Acute appendicitis is the most commonly performed emergency surgery in the United States and is unlikely to improve without medical or surgical intervention. Dramatic reductions in E.D. visits prompted concern that individuals with severe conditions, such as acute appendicitis, deferred treatment for fear of contracting COVID-19. Appendicitis patient admissions in 2020 decreased throughout march into april, with april experiencing the fewest admissions. However, the incidence of acute appendicitis was slightly lower during the first wave of the 2020 COVID-19 pandemic. More patients presented with a delay and with complicated appendicitis than in a corresponding period in 2019.

Segment Analysis

The acute type appendicitis segment has dominated the market

Acute appendicitis is a widespread surgical emergency diagnosed by combining the history, examination, and investigations with building a clinical picture. Traditionally, appendectomy has been the treatment for acute appendicitis. Several diagnostic scoring systems for acute appendicitis have been described. The most commonly used are the Alvarado score and AIR-Appendicitis Inflammatory Response (Andersson) score. Both of these scoring systems can increase the diagnostic accuracy, thus guiding the decision-making and decreasing the need of potentially harmful and expensive imaging. It is the most common surgical disease with a lifetime risk of 7-8%. Although many controversies exist regarding non-operative management of AA, antibiotics play an important role in the treatment of patients with AA as demonstrated by several prospective trials and meta-analyses. Therefore, the comparison of surgery and antibiotic therapy still remains a challenging and debated issue which will drive the global appendicitis diagnostics and treatment market.

The treatment segment is expected to dominate the market

Appendicitis treatment usually involves surgery to remove the inflamed appendix. Appendectomy is the surgery done to remove the appendix. It is the standard treatment for almost all cases of appendicitis. The surgery is done by one of the following methods like laparoscopic surgery or laparotomy.In laparoscopic surgery, surgeons use several smaller incisions and special surgical tools that they feed through the incisions to remove appendix. Laparoscopic surgery leads to fewer complications, such as hospital-related infections, and has a shorter recovery time.Whereas laparotomy is used to remove the appendix through a single incision in the lower right area of your abdomen. For minimally invasive procedures laproscopy surgery is most commonly preferred.

With recent development, treatment with Robot-assisted procedures accounted for 15.1% of all general surgeries in 2018.Hospitals that rolled out robotic surgery programs saw a broad and immediate increase in such procedures and corresponding decrease in laparoscopic surgery, which is also minimally invasive.

The diagnostic segment is expected to dominate the Global Appendicitis Diagnostics and Treatment Market. in the forecast period

The symptoms of appendicitis may not be typical,further tests may be needed to confirm the diagnosis and rule out other conditions. There are different diagnostic tests available in recent times for the diagnosis of appendicitis. For example blood tests, it can show a high white blood cell count as a sign of infection. Urinalysis is also done to rule out a urinary tract infection or a kidney stone.For women, doctors may also order blood or urine samples to check for pregnancy.

Imaging test is the best diagnosis for appendicitis and other causes of pain in the abdomen.In an abdominal ultrasound, doctor uses a device, called a transducer, to bounce safe, painless sound waves off of your organs to create an image of their structure. A radiologist reviews the images, which can show signs of a blockage in your appendiceal lumen, a burst appendix, inflammation and other sources of abdominal pain

Doctors use ultrasound as the first imaging test for diagnosis of appendicitis in children, young adults, and pregnant women.An MRI(Magnetic resonance imaging) can show signs of a blockage in your appendiceal lumen, a burst appendix, inflammation and sources of abdominal pain.When diagnosing appendicitis and other sources of abdominal pain, MRI can be used as a safe, reliable alternative to a computerized tomography (C.T.) scan. C.T. scan uses x-rays and computer technology to create images. It shows an enlarged or a burst appendix, an appendiceal abscess and a blockage in appendiceal lumen.Women of childbearing age should have a pregnancy test before having a C.T. scan because the radiation from C.T. scans can be harmful to a developing fetus.

Geographical Analysis

North America region dominates the Global Appendicitis Diagnostics and Treatment Market. mainly due to the growing prevalence of appendicitis and increased awareness of the disease, and the demand for effective treatment. As per research, in 2018, the incidence of acute appendicitis in the United States was 10 per 100,000 people. Appendicitis is likely to affect around 7% of the global United States population, with an incidence rate of 1.1 cases in 1,000 people every year. The lifetime risk of appendicitis is 1 in 15 in the United States. One-third of appendicitis cases present to the hospital with a perforated appendix. The healthcare expenditure in the U.S has increased from previous years, which may see accelerated growth in the medical devices industry.

According to preliminary projections from CMS' Office of the Actuary published in Health Affairs. National health care spending in the United States is expected to grow at an average annual rate of 5.4% from 2019 to 2028, outpacing the gross domestic product's (GDP) average annual growth rate of 4.3%.In the report, CMS estimated that prices for medical goods and services would grow at an average annual rate of 2.4% from 2019 to 2028 and would account for 43% of total projected growth in personal health care spending during that time.

Competitive Landscape

The Global Appendicitis Diagnostics and Treatment Market. is moderately competitive with the presence of local as well as global companies. Some prominent key players in this market are Johnson & Johnson Services Inc, Pfizer Inc, Lupin, Siemens, Koninklijke Philips NV, Becton, Dickinson and Company, B. Braun Melsungen AG, Cook, Medtronic, Teva Pharmaceutical Industries Ltd, Medsinglong Co Ltd., Guangzhou Medunion Technologies Co.ltd and Guangzhou Maya Medical Equipment.Co.ltd

Key Companies to Watch

B. Braun Melsungen AG

Overview: B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the company's deep understanding of users' needs, and more than 180 years of extensive expertise. With its constantly growing portfolio of adequate medical care solutions, B. Braun contributes towards protecting and improving people's health. The B. Braun product range comprises 5,000 different products, 95 percent of which are manufactured by the company. In addition, by offering supplementary services and consulting, B. Braun is a system supplier that develops the best solution for patients in close partnership with our customers, making a significant contribution to medical advancements.

Product Portfolio: The Company offers effective medical care solutions and focuses on the further systematic development of the EinsteinVision 3D camera system, vessel sealing and closure instruments such as Caiman and D.S. appendectomy clips, as well as hand-held instruments.

Key Development: On Aug. 5, 2020, B. Braun Medical Inc. (B. Braun) and Kerma Medical Products, Inc. (Kerma) announced a collaboration to improve the development and delivery of healthcare products and services with an emphasis on veteran, minority and other underserved communities. The companies will work together in various areas, including product development, co-marketing opportunities, strategic sourcing, sustainable manufacturing, and diversity programs.

Why Purchase the Report?

  • Visualize the composition of the Global Appendicitis Diagnostics and Treatment Market. segmentation by Type, Diagnosis & Treatment and End-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in Global Appendicitis Diagnostics and Treatment Market. by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of Global Appendicitis Diagnostics and Treatment Market. - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The Global Appendicitis Diagnostics and Treatment Market. report would provide an access to an approx. 60 market data table, 49 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Appendicitis Diagnostics and Treatment Market. - By Type

  • Acute
  • Chronic

Global Appendicitis Diagnostics and Treatment Market. - By Diagnosis & Treatment

  • Diagnosis

Ultrasound Imaging

CT Scan

Others

  • Treatment

Medication

Surgery

  • Others

Global Appendicitis Diagnostics and Treatment Market. - By End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Global Appendicitis Diagnostics and Treatment Market. - By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Global Appendicitis Diagnostics and Treatment Market. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Appendicitis Diagnostics and Treatment Market. - Market Definition and Overview

3. Global Appendicitis Diagnostics and Treatment Market. - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Diagnosis & Treatment
  • 3.3. Market Snippet by End User

4. Global Appendicitis Diagnostics and Treatment Market. - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising prevalence of appendicitis and incidence of pediatric appendicitis will drive the market growth.
      • 4.1.1.2. Growing demand for diagnostic and treatment options
    • 4.1.2. Restraints:
      • 4.1.2.1. Difficulty in the diagnosis of appendicitis will hamper the market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Appendicitis Diagnostics and Treatment Market. - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Appendicitis Diagnostics and Treatment Market. - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Appendicitis Diagnostics and Treatment Market. - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Acute*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Chronic

8. Global Appendicitis Diagnostics and Treatment Market. - By Diagnosis & Treatment

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis & Treatment
    • 8.1.2. Market Attractiveness Index, By Diagnosis & Treatment
  • 8.2. Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 8.2.3. Ultra Sound Imaging
    • 8.2.4. CT Scan
    • 8.2.5. Others
  • 8.3. Treatment
    • 8.3.1 Medication
    • 8.3.2 Surgery
  • 8.4.Others

9. Global Appendicitis Diagnostics and Treatment Market. - By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 9.1.2. Market Attractiveness Index, By End User Segment
  • 9.2. Hospitals & Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Diagnostic Centers

10. Global Appendicitis Diagnostics and Treatment Market. - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByType
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis & Treatment
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByType
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis & Treatment
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByType
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis & Treatment
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByType
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis & Treatment
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), ByType
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis & Treatment
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Appendicitis Diagnostics and Treatment Market. - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch
  • 11.5. List of Company with disruptive technology
  • 11.6. List of Start Up Companies

12. Global Appendicitis Diagnostics and Treatment Market.Market- Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Johnson & Johnson Services Inc
  • 12.3. Pfizer Inc
  • 12.4. Lupin
  • 12.5. Siemens
  • 12.6. Koninklijke Philips NV
  • 12.7. Medsinglong Co Ltd.
  • 12.8. Guangzhou Medunion Technologies Co.ltd
  • 12.9. Guangzhou Maya Medical Equipment.Co.ltd
  • 12.10. Teva Pharmaceutical Industries Ltd

LIST NOT EXHAUSTIVE

13. Global Appendicitis Diagnostics and Treatment Market. - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us